Levetiracetam Adoh

Levetiracetam, the active ingredient in Levetiracetam Adoh, is an anticonvulsant presented as an intravenous solution for intravenous use. It treats partial‑onset, generalized tonic‑clonic, and myoclonic seizures in patients who require parenteral therapy.

GNH USA supplies Levetiracetam Adoh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to manage seizure disorders.

- Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy. - Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. - Myoclonic seizures: decreases myoclonic jerks in appropriate patient populations.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Fatigue: persistent tiredness not relieved by rest. - Headache: mild to moderate cranial pain. - Somnolence: increased sleepiness during the day. - Irritability: mood changes or agitation. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Blood dyscrasias: abnormal blood counts. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe skin rash: extensive erythema or blistering. - Respiratory depression: marked reduction in breathing effort.

Levetiracetam requires careful monitoring in specific clinical situations.

- Renal impairment: assess renal function and adjust monitoring as needed. - Hepatic impairment: use caution and monitor liver enzymes. - Pregnancy: risk unknown; evaluate benefit‑risk ratio. - Concomitant CNS depressants: monitor for enhanced sedation. - Discontinue if severe rash: stop therapy immediately and seek medical attention. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenytoin: potential reduction in levetiracetam exposure. - Phenobarbital: enzyme induction may decrease levetiracetam concentration.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression. - Sedating antihistamines: increased drowsiness. - Opioids: heightened risk of respiratory depression. - Certain antidepressants: possible enhancement of central effects. - Other antiepileptics: monitor overall seizure control and side‑effect profile.